Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian J Hinderer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Communications Biology|October 27, 2023
Quantification of human mature frataxin protein expression in nonhuman primate hearts after gene therapyTeerapat Rojsajjakul, Juliette J Hordeaux, Gourav R Choudhury, et al.
Human Gene Therapy|January 31, 2023
Neonatal Fc Receptor Inhibition Enables Adeno-Associated Virus Gene Therapy Despite Pre-Existing Humoral ImmunityMakoto Horiuchi, Christian J Hinderer, Hailey N Shankle, et al.
Molecular Therapy. Methods & Clinical Development|November 2, 2022
Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectorsMakoto Horiuchi, Christian J Hinderer, Jenny A Greig, et al.
Molecular Therapy. Methods & Clinical Development|November 24, 2022
Erratum: Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectorsMakoto Horiuchi, Christian J Hinderer, Jenny A Greig, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2024
Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosisKaren J Quadrini, Catherine Vrentas, Christian Duke, et al.
Journal of Veterinary Internal Medicine|October 17, 2023
Adeno-associated virus-vectored erythropoietin gene therapy for anemia in cats with chronic kidney diseaseShelly L Vaden, Allison R Kendall, Jonathan D Foster, et al.
Science Translational Medicine|July 19, 2013
Overcoming preexisting humoral immunity to AAV using capsid decoysFederico Mingozzi, Xavier M Anguela, Giulia Pavani, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Communications Biology|October 27, 2023
Quantification of human mature frataxin protein expression in nonhuman primate hearts after gene therapyTeerapat Rojsajjakul, Juliette J Hordeaux, Gourav R Choudhury, et al.
Human Gene Therapy|January 31, 2023
Neonatal Fc Receptor Inhibition Enables Adeno-Associated Virus Gene Therapy Despite Pre-Existing Humoral ImmunityMakoto Horiuchi, Christian J Hinderer, Hailey N Shankle, et al.
Molecular Therapy. Methods & Clinical Development|November 2, 2022
Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectorsMakoto Horiuchi, Christian J Hinderer, Jenny A Greig, et al.
Molecular Therapy. Methods & Clinical Development|November 24, 2022
Erratum: Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectorsMakoto Horiuchi, Christian J Hinderer, Jenny A Greig, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2024
Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosisKaren J Quadrini, Catherine Vrentas, Christian Duke, et al.
Journal of Veterinary Internal Medicine|October 17, 2023
Adeno-associated virus-vectored erythropoietin gene therapy for anemia in cats with chronic kidney diseaseShelly L Vaden, Allison R Kendall, Jonathan D Foster, et al.
Science Translational Medicine|July 19, 2013
Overcoming preexisting humoral immunity to AAV using capsid decoysFederico Mingozzi, Xavier M Anguela, Giulia Pavani, et al.
Pageof 1